Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer.
Mazzanti P, Massacesi C, Rocchi MB, Mattioli R, Lippe P, Trivisonne R, Buzzi F, De Signoribus G, Tuveri G, Rossi G, Di Lullo L, Sturba F, Morale D, Catanzani S, Pilone A, Bonsignori M, Battelli T.
Mazzanti P, et al. Among authors: tuveri g.
Lung Cancer. 2003 Jul;41(1):81-9. doi: 10.1016/s0169-5002(03)00140-5.
Lung Cancer. 2003.
PMID: 12826316
Clinical Trial.